Clinical value of the wild-type estrogen receptor beta expression in breast cancer (Q31880259)

4 July 2017

title

Clinical value of the wild-type estrogen receptor beta expression in breast cancer (English)

1 reference

4 July 2017

1 reference

1 reference

Omoto Y

1

1 reference

4 July 2017

Inoue S

2

1 reference

4 July 2017

Ogawa S

3

1 reference

4 July 2017

Toyama T

4

1 reference

4 July 2017

Yamashita H

5

1 reference

4 July 2017

Muramatsu M

6

1 reference

4 July 2017

Kobayashi S

7

1 reference

4 July 2017

Iwase H

8

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

volume

163

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

207-212

1 reference

Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Estrogen receptors alpha and beta form heterodimers on DNA

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Estrogen receptor-beta mRNA variants in human and murine tissues

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Identification of a splice variant of the rat estrogen receptor β gene

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Cloning and characterization of human estrogen receptor beta isoforms

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Clinical Significance of Estrogen Receptor Àin Breast Cancer

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Expression of estrogen receptor-beta in human breast tumors

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(00)00680-7

7 January 2021

10.1016/S0304-3835(00)00680-7

Identifiers

DOI

1 reference

4 July 2017

1 reference